HM-15275
- Generic Name
- HM-15275
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 74
- Registration Number
- NCT06481098
- Locations
- 🇺🇸
ProSciento, Inc., Chula Vista, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath